- Home
- CORT vs KTOS Comparison
CORT vs KTOS Comparison
Compare CORT & KTOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CORT
- KTOS
- Stock Information
- Founded
- CORT 1998
- KTOS 1994
- Country
- CORT United States
- KTOS United States
- Employees
- CORT N/A
- KTOS N/A
- Industry
- CORT Biotechnology: Pharmaceutical Preparations
- KTOS Military/Government/Technical
- Sector
- CORT Health Care
- KTOS Industrials
- Exchange
- CORT Nasdaq
- KTOS Nasdaq
- Market Cap
- CORT 8.8B
- KTOS 10.0B
- IPO Year
- CORT N/A
- KTOS 1999
- Fundamental
- Price
- CORT $76.81
- KTOS $90.58
- Analyst Decision
- CORT Strong Buy
- KTOS Buy
- Analyst Count
- CORT 4
- KTOS 14
- Target Price
- CORT $139.00
- KTOS $73.43
- AVG Volume (30 Days)
- CORT 1.0M
- KTOS 6.3M
- Earning Date
- CORT 10-29-2025
- KTOS 11-06-2025
- Dividend Yield
- CORT N/A
- KTOS N/A
- EPS Growth
- CORT N/A
- KTOS 31.73
- EPS
- CORT 1.11
- KTOS 0.09
- Revenue
- CORT $716,080,000.00
- KTOS $1,213,100,000.00
- Revenue This Year
- CORT $30.77
- KTOS $17.66
- Revenue Next Year
- CORT $37.75
- KTOS $18.10
- P/E Ratio
- CORT $70.90
- KTOS $957.34
- Revenue Growth
- CORT 25.71
- KTOS 7.76
- 52 Week Low
- CORT $42.01
- KTOS $22.69
- 52 Week High
- CORT $117.33
- KTOS $112.57
- Technical
- Relative Strength Index (RSI)
- CORT 45.45
- KTOS 59.01
- Support Level
- CORT $69.43
- KTOS $92.91
- Resistance Level
- CORT $91.00
- KTOS $112.57
- Average True Range (ATR)
- CORT 4.07
- KTOS 5.99
- MACD
- CORT -1.83
- KTOS -0.14
- Stochastic Oscillator
- CORT 34.21
- KTOS 34.75
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.
About KTOS Kratos Defense & Security Solutions Inc.
Kratos Defense & Security Solutions Inc develops and fields transformative, affordable technology, platforms, and systems. The company has two segments; The Kratos Government Solutions (KGS) segment is comprised of an aggregation of KGS operating segments, including its microwave electronic products, space, training, and cybersecurity, C5ISR/modular systems, turbine technologies, and defense and rocket support services operating segments and The Unmanned Systems segment consists of unmanned aerial, unmanned ground, unmanned seaborne and related command, control, and communications system businesses. The company derives a majority of its revenue from the Kratos Government Solutions segment.